Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation

E-ISSN： 1749-6632|1348|1|116-123

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1348, Iss.1, 2015-08, pp. : 116-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Pathway – Novel Modulator of Astrocyte Activity

By Latacz Anna Russell John A. Ocłoń Ewa Zubel-Łojek Joanna Pierzchała-Koziec Krystyna

Folia Biologica, Vol. 63, Iss. 2, 2015-04 ,pp. : 95-105

Institute of Systematics and Evolution of Animals, Polish Academy of Sciences

Access to resources Recommend Favorite

The mTOR Signalling Pathway in Human Cancer

By Pópulo Helena Lopes José Manuel Soares Paula

International Journal of Molecular Sciences, Vol. 13, Iss. 2, 2012-02 ,pp. : 1886-1918

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif Hashimi Saeed M. Wei Ming Q.

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

Expression profiles of mTOR pathway proteins in porocarcinoma: A provisional immunohistochemical study

By Ishida Okabe

Biomedical Reports, Vol. 1, Iss. 1, 2013-01 ,pp. : 28-30

Spandidos Publications

Access to resources Recommend Favorite

Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway

By Le Sage Valerie Cinti Alessandro Amorim Raquel Mouland Andrew J.

Viruses, Vol. 8, Iss. 6, 2016-05 ,pp. : 152-152

MDPI

Access to resources Recommend Favorite